ENSYSCE BIOSCIENCES INC (ENSC)
US2936024056 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.53M | 2.52M -28.61% | 2.231M -11.49% | 2.499M 12.04% | -100.00% | 47.763M | 89.062M 86.47% | |
| EBITDA YoY % growth | -19.87M | -24.23M -21.94% | N/A 54.32% | -20.089M -81.50% | -22.748M -13.24% | -11.836M 47.97% | 10.687M 190.29% | |
| EBIT YoY % growth | -19.87M -1,350.36% | -24.23M -21.94% | -10.718M 55.76% | -7.353M 31.40% | -14.743M -100.50% | -11.871M 19.48% | 10.251M 186.36% | |
| Operating Margin | -562.89% | -961.51% | -480.52% | -294.24% | N/A | -24.85% | 11.51% | |
| EPS YoY % growth | N/A | -99.12 52.64% | -5.30 94.65% | -12.70 -139.60% | -13.01 -2.41% | 85.99 761.18% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.18 86.60% | -0.20 62.91% | -0.21 2.64% | -0.23 -435.14% | -0.21 -16.67% |
| Revenue Q2Q % growth | 255K -50.49% | -100.00% | -100.00% | -100.00% | -100.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 0.07 108.05% | -0.30 | 0.37 | 123.26% |
| Q2 2024 Q2Q % growth | -0.22 77.55% | -0.40 | 0.18 | 44.70% |
| Q1 2024 Q2Q % growth | -0.55 73.56% | -0.92 | 0.37 | 40.09% |
| Q4 2023 Q2Q % growth | -1.37 92.49% | -0.89 | -0.48 | -54.38% |
| Q3 2023 Q2Q % growth | -0.87 90.20% | -1.08 | 0.21 | 19.28% |
| Q2 2023 Q2Q % growth | -0.98 98.30% | -2.78 | 1.80 | 64.76% |
| Q1 2023 Q2Q % growth | -2.08 85.56% | -5.18 | 3.10 | 59.83% |
| Q4 2022 Q2Q % growth | -18.24 83.11% | -29.46 | 11.22 | 38.08% |
| Q3 2022 Q2Q % growth | -8.88 -1,150.70% | -39.17 | 30.29 | 77.33% |
| Q2 2022 Q2Q % growth | -57.60 | -41.62 | -15.98 | -38.41% |
| Q1 2022 Q2Q % growth | -14.40 | -39.17 | 24.77 | 63.24% |
| Q4 2021 Q2Q % growth | -108.00 | -4.90 | -103.10 | -2,105.88% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.419M 685.29% | 255K | 3.164M | 1,240.78% |
| Q2 2024 Q2Q % growth | 181.8K -62.90% | 306K | -124.2K | -40.59% |
| Q1 2024 Q2Q % growth | 305.72K -61.30% | 408K | -102.28K | -25.07% |
| Q4 2023 Q2Q % growth | 515.03K -63.98% | 402.9K | 112.13K | 27.83% |
| Q3 2023 Q2Q % growth | 435.38K 55.49% | 605.197K | -169.817K | -28.06% |
| Q2 2023 Q2Q % growth | 490K 133.33% | 843.203K | -353.203K | -41.89% |
| Q1 2023 Q2Q % growth | 790K 31.67% | 969K | -179K | -18.47% |
| Q4 2022 Q2Q % growth | 1.43M -12.80% | 1.571M | -141K | -8.98% |
| Q3 2022 Q2Q % growth | 280K -76.67% | 1.02M | -740K | -72.55% |
| Q2 2022 Q2Q % growth | 210K -52.27% | 1.02M | -810K | -79.41% |
| Q1 2022 Q2Q % growth | 600K 140.00% | 1.224M | -624K | -50.98% |
| Q4 2021 Q2Q % growth | 1.64M | 1.02M | 620K | 60.78% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 35.71% | 44.62% | -770.63% | -770.63% |
| Revenue | 2.04% | -15.25% | 133.33% | 133.33% |